WHO activities to support the South Pacific

The objectives of the program are to speed enhanced accessibility, quality, and use of essential medicines and other key pharmaceuticals in Pacific countries through:

  • Developing, implementing and monitoring national medicines policies;
  • Increase equitable access to essential medicines, particularly for priority health problems including adaptation of the TRIPS implementation;
  • Ensuring the quality, safety and efficacy of medicines through effective drug regulation;
  • Improving rational use of medicines by health professionals and consumers.

The programme results

  • Increased capacity of countries to develop, implement, and monitor the impact of national medicine policies, with an emphasis on equitable access to essential medicines.
  • Greater ability of regional institutions and countries to negotiate in international for a and monitor the impact of international trade agreements on access to medicines as well as a greater number of countries with related legislation and regulation which supports access to medicines, in particular through adaptation of TRIPS implementation.
  • Improved affordability and financing of essential medicines in both the public and private sectors through active use of price information, generic competition, differential pricing, reduced tariffs and taxes, benchmarks for public financing and expanded use of new drug finances strategies.
  • More reliable and efficient drug supply management systems in both the public and private sectors at country level, including, where appropriate, development of regional pooled procurement and sustainable local drug production.
  • Strengthened norms, standards and guidelines for the quality, safety and efficacy of medicines, including new pharmaceutical tests and coordinated regional and international harmonization of norms.
  • Increased capacity in countries for effective drug regulation and quality assurance systems, with improved inspection practices, combating substandard and counterfeit drugs and reliable information management systems.
  • More rational prescribing and dispensing of medicines by health professionals and containment of antimicrobial resistance in countries through training and regional network.
  • More rational use of medicines by patients and consumers through public awareness campaigns and linkages with existing and developing consumer groups in countries